Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2025 Earnings Call Transcript
Operator: Good day, everyone, and thank you for standing by. My name is RG, and I will be your conference operator today.
Seres Therapeutics Inc. (MCRB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 125,600 | $2,416,543 | +38% | 0% |
| 2. | 125,000 | $2,405,000 | 0.01% | ||
| 3. | Citadel Investment Group Ken Griffin | 30,885 | $594,227 | 0% | |
| 4. | 30,010 | $577,392 | +180% | 0% | |
| 5. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 28,942 | $556,843 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.15 | 5,825,495 | $18,350,309.25 | 5,825,495 | 2022-07-05 | Filing | |
| $3.15 | 2,912,748 | $9,175,156.20 | 5,875,711 | 2022-07-05 | Filing | |
| $2.25 | 4,444,444 | $9,999,999.00 | 4,444,444 | 2019-06-18 | Filing | |
| $2.25 | 4,444,444 | $9,999,999.00 | 4,444,444 | 2019-06-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.30 | 1,042 | $18,026.60 | 8,401 | 2025-11-15 | Filing | |
| $17.30 | 217 | $3,754.10 | 11,113 | 2025-11-15 | Filing | |
| $17.30 | 76 | $1,314.80 | 7,623 | 2025-11-15 | Filing | |
| $17.30 | 1,257 | $21,746.10 | 7,527 | 2025-11-15 | Filing | |
| $16.65 | 217 | $3,613.05 | 10,609 | 2025-08-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,155,850 | $22,238,554 | 7.6% | |
| 2. | 316,300 | $6,085,612 | 0% | |
| 3. | 311,889 | $6,000,745 | 0% | |
| 4. | 102,060 | $1,963,635 | 0% | |
| 5. | 98,511 | $1,895,352 | 0.01% |
News See All
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Seres Therapeutics Second Quarter 2025 Results and Business Update Call. [Operator Instructions] Please note, this call is being recorded.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Kate, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Bella, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. At this time, I would like to welcome everyone to Seres Therapeutics Second Quarter 2024 Earnings Conference Call.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Alex, and I will be your conference operator today.
11 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now.
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, good morning. My name is Abby, and will be your conference operator today.